3. Variability of SBP and DBP at end of treatment.
ACE Inhibitor | Placebo | ||
SBP | Weighted mean SD | 16.6 | 16.8 |
SD of weighted mean SD | 3.1 | 3.0 | |
Weighted mean SBP | 146.0 | 152.9 | |
Weighted mean coefficient of variation (CV) | 11.2 | 11.0 | |
SD of weighted mean CV | 2.1 | 2.0 | |
Number of observations | 22 | 19 | |
DBP | Weighted mean SD | 9.0 | 8.9 |
SD of weighted mean SD | 1.7 | 1.8 | |
Weighted mean DBP | 91.8 | 96.4 | |
Weighted mean coefficient of variation (CV) | 9.8 | 9.2 | |
SD of weighted mean CV | 1.8 | 1.9 | |
Number of observations | 20 | 18 | |
t‐test | SD of SBP vs SD of DBP | p < 0.0001 | p < 0.0001 |
t‐test | CV SBP vs CV DBP | p = 0.0227 | p = 0.0045 |